Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

Abstract Background Patient-related factors such as concern about cancer are believed to influence both men’s decisions to undergo prostate specific antigen (PSA) testing and to have definitive treatment if diagnosed with low risk prostate cancer (PCa). The potential link between screening frequency...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Kerri Beckmann, Netty Kinsella, Henrik Olsson, Anna Wallerstedt Lantz, Tobias Nordstrom, Markus Aly, Jan Adolfsson, Martin Eklund, Mieke Van Hemelrijck
Formatua: Artikulua
Hizkuntza:English
Argitaratua: BMC 2019-08-01
Saila:BMC Urology
Gaiak:
Active surveillance
PSA testing
Screening
Prostate biopsy
Prostate neoplasm
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s12894-019-0502-4

Internet

http://link.springer.com/article/10.1186/s12894-019-0502-4

Antzeko izenburuak